Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Say yes to the prenup? Why younger Canadians feel the love amid uncertainty

February 9, 2026

New Crypto Protocol Mutuum Finance Reports MUTM Growth and Investor Base Since Q1 2025

February 9, 2026

Olympic medals are already falling apart, and we’re not even a week in

February 9, 2026

At 20th Stevie® Awards, ValueSelling Associates Wins its 6th Grand Stevie Award as its Clients Earn 17 Honors for Best in Sales and Customer Service

February 9, 2026

Toll Brothers Announces New Luxury Home Community Coming Soon to San Bruno, California

February 9, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Truveta deepens regulatory science leadership with appointment of John D. Seeger, PharmD, DrPH, FISPE as Senior Vice President of Evidence Services
Press Release

Truveta deepens regulatory science leadership with appointment of John D. Seeger, PharmD, DrPH, FISPE as Senior Vice President of Evidence Services

By News RoomFebruary 9, 20263 Mins Read
Truveta deepens regulatory science leadership with appointment of John D. Seeger, PharmD, DrPH, FISPE as Senior Vice President of Evidence Services
Share
Facebook Twitter LinkedIn Pinterest Email
Truveta deepens regulatory science leadership with appointment of John D. Seeger, PharmD, DrPH, FISPE as Senior Vice President of Evidence Services

BELLEVUE, Wash., Feb. 09, 2026 (GLOBE NEWSWIRE) — Truveta today announced the appointment of John D. Seeger, PharmD, DrPH, FISPE, a global leader in pharmacoepidemiology, to lead Truveta Evidence Services. In this role, Dr. Seeger will advance Truveta’s life science partners’ research with Truveta Data for regulatory decision making.

Dr. Seeger brings more than three decades of experience designing, leading, and evaluating large-scale observational research used to inform regulatory decision-making, drug safety, comparative effectiveness, and public health policy worldwide. Under his leadership, Truveta Evidence Services will continue to expand its ability to deliver fit-for-purpose evidence at the speed, scale, and scientific rigor required by today’s regulatory and research environments.

“Trusted evidence is foundational to better decisions in medicine, science, and public health,” said Terry Myerson, CEO and co-founder of Truveta. “John is one of the most respected leaders in real-world evidence globally. His expertise deepens our capability to deliver scientifically rigorous research at scale. That is how we save lives with data.”

Prior to joining Truveta, Dr. Seeger served as VP for Epidemiology for RTI-HS and Chief Scientific Officer for Epidemiology at Optum, where he provided scientific and strategic leadership for large, multidisciplinary epidemiology teams supporting life sciences and regulatory clients. He has also held academic appointments at Harvard Medical School and the Harvard T.H. Chan School of Public Health and served as President of the International Society for Pharmacoepidemiology. Dr. Seeger has authored hundreds of peer-reviewed publications across drug safety, vaccine surveillance, comparative effectiveness, and regulatory science.

“Truveta’s unique combination of health system–owned data, advanced analytics, and deep scientific rigor creates a powerful platform for generating real-world evidence that meets the highest regulatory standards,” said Dr. Seeger. “I’m excited to help partners across life sciences, healthcare, government, and academia move faster from data to trusted evidence—ultimately improving patient outcomes.”

Dr. Seeger’s vision for the future of pharmacoepidemiology involves moving beyond traditional drug safety paradigms that check the boxes but have limited application. By integrating clinical and regulatory insights with rigorous methods and reliable, de-identified patient-level data, we can produce transformational research results that benefit patients and all those who care for them.

Ryan Ahern, MD, MPH, Truveta’s Chief Medical Officer and co-founder, added, “Our customers and partners know how deeply we care about the quality, integrity, and purpose of our data. John’s unparalleled expertise in epidemiology and regulatory-grade real-world evidence further strengthens our ability to deliver trusted insights at scale and to support decisions that advance science and improve patient outcomes.”

Dr. Seeger joins Truveta alongside Johnathan Lancaster, MD, PhD, President and Chief Scientific Officer, as the company continues to expand its scientific leadership in service of its mission of Saving Lives with Data.

About Truveta

Saving Lives with Data starts with better evidence. Truveta is a real-world intelligence company unlocking breakthrough discoveries and transforming medicine with unprecedented data and predictive AI. Built with and owned by U.S. health systems, we deliver regulatory-grade evidence and real-time insights used across clinical care, research, and public health.

Truveta membership includes Providence, Advocate Health, Trinity Health, Tenet Healthcare, Northwell Health, AdventHealth, Baptist Health of Northeast Florida, Baylor Scott & White Health, Bon Secours Mercy Health, CommonSpirit Health, Hawaii Pacific Health, HealthPartners, Henry Ford Health System, HonorHealth, Inova, Lehigh Valley Health Network, MedStar Health, Memorial Hermann Health System, MetroHealth, Novant Health, Ochsner Health, Premier Health, Saint Luke’s Health System, Sanford Health, Sentara Healthcare, Texas Health Resources, TriHealth, UnityPoint Health, Virtua Health, and WellSpan Health.

  • of John D. Seeger, PharmD, DrPH, FISPE as Senior Vice President of Evidence Services, Truveta
            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

New Crypto Protocol Mutuum Finance Reports MUTM Growth and Investor Base Since Q1 2025

At 20th Stevie® Awards, ValueSelling Associates Wins its 6th Grand Stevie Award as its Clients Earn 17 Honors for Best in Sales and Customer Service

Toll Brothers Announces New Luxury Home Community Coming Soon to San Bruno, California

Monarch Private Capital and FilmUSA Recap “Lights. Camera. America!” Panel at the 2026 Sundance Film Festival on the Future of U.S. Film Production

Indonesia Data Center Industry Report 2026: Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2025-2031

Lil Wayne Performs Halftime Show in Hit Mobile Game Clash Royale

SVCV Launches NextRock Investment Group as the Flagship Financial Firm and Global Asset Manager for the Group

Cygnet.One Approved as an AWS Amazon ECS Service Delivery Partner

Logistics Automation Research Report 2026 – Rapid E-Commerce Parcel Volumes Drive Infrastructure Modernization – Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2025-2031

Editors Picks

New Crypto Protocol Mutuum Finance Reports MUTM Growth and Investor Base Since Q1 2025

February 9, 2026

Olympic medals are already falling apart, and we’re not even a week in

February 9, 2026

At 20th Stevie® Awards, ValueSelling Associates Wins its 6th Grand Stevie Award as its Clients Earn 17 Honors for Best in Sales and Customer Service

February 9, 2026

Toll Brothers Announces New Luxury Home Community Coming Soon to San Bruno, California

February 9, 2026

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

Linux 6.19 arrives with a teaser for Linux 7.0

February 9, 2026

Monarch Private Capital and FilmUSA Recap “Lights. Camera. America!” Panel at the 2026 Sundance Film Festival on the Future of U.S. Film Production

February 9, 2026

Indonesia Data Center Industry Report 2026: Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2025-2031

February 9, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version